FDA approves immunotherapy drug combo for non-muscle invasive bladder cancer after UCLA-led research

The FDA approval was based on results of the QUILT 3.032 clinical trial, which was led by Dr. Karim Chamie, associate professor urology at the David Geffen ... Read more

Bron:

Newswise: MedNews